Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
Pancreatic neuroendocrine tumors (pNETs) are unique, slow-growing malignancies whose molecular pathogenesis is incompletely understood. With rising incidence of pNETs over the last four decades, larger and more comprehensive ‘omic’ analyses of patient tumors have led to a clearer picture of the pNET...
Main Authors: | Chandra K. Maharjan, Po Hien Ear, Catherine G. Tran, James R. Howe, Chandrikha Chandrasekharan, Dawn E. Quelle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/20/5117 |
Similar Items
-
Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods
by: Xuejiao Han, et al.
Published: (2021-07-01) -
Von Hippel-Lindau is Associated to Pancreatic Neuroendocrine Tumors: A Comprehensive Review
by: Danilo Coco, et al.
Published: (2023-05-01) -
Misdiagnosed cystic pancreatic neuroendocrine tumor with bilobar hepatic metastasis managed with single-stage resection — a case report
by: Maham Nasir Uddin, et al.
Published: (2023-12-01) -
Hyperammonemic Encephalopathy in a Patient with Pancreatic Neuroendocrine Tumor and Portosystemic Shunt
by: Marcel Zorgdrager, et al.
Published: (2023-02-01) -
Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
by: Wentong Mei, et al.
Published: (2023-03-01)